We evaluated the risk of recurrent viremia in active PWID after achieving a sustained virologic response as a result of treatment in a multidisciplinary care facility, with enhanced long-term follow-up. Rates of recurrent viremia in this setting were lower compared to when treatment was implanted in a traditional clinical setting - highlighting the efficacy of this model.
Impact Factor
2022: 6.012
This work is licensed under a